4 trends to know about private equity in gastroenterology — Multiples, market potential & more

Written by Rachel Popa | March 11, 2019 | Print  |

High gastroenterology private equity activity will continue in 2019, according to Kerri Zelensek, McGuireWoods associate, and Tom Zahn, partner at McGuireWoods. Mr. Zahn and Ms. Zelensek attended the 6th Annual Healthcare and Life Sciences Private Equity and Finance Conference, February 20 and 21 in Chicago, and outlined the key takeaways on JDSupra.

The key trends to know:

1. Gastroenterology is a fragmented market, which may impact private equity opportunities. Gastroenterologists are accustomed to working independently, making combinations and add-ons challenging.

2. Gastroenterology multiples vary due to differences in infrastructure and practice sophistication. Multiples will likely be lower for add-in deals and for practices without an established infrastructure. Conference panelists said they've seen multiples in the low teens or high single digits for practices with a strong internal structure.

3. Commercializing gastroenterology ancillaries is key in gastroenterology. Structured ancillaries can form lucrative investments and benefit physicians' practices.

4. Before a practice comes to market, there should be an agreed-upon, transparent formula for physician compensation.

More articles on gastroenterology:
Drs. Charles Friel, Vaibhav Wadhwa & more: 4 GI physicians making headlines
GI leader to know: Dr. Rajesh Keswani of Northwestern Medicine
Hospital acquires Cumberland Gastroenterology — 4 insights

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

To receive the latest hospital and health system business and legal news and analysis from Becker's Hospital Review, sign-up for the free Becker's Hospital Review E-weekly by clicking here.